Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with in-vitro and in-situ validation
BackgroundGastric cancer (GC) represents a malignancy with a multi-factorial combination of genetic, environmental, and microbial factors. Targeting lysosomes presents significant potential in the treatment of numerous diseases, while lysosome-related genetic markers for early GC detection have not...
Main Authors: | Qi Wang, Ying Liu, Zhangzuo Li, Yidan Tang, Weiguo Long, Huaiyu Xin, Xufeng Huang, Shujing Zhou, Longbin Wang, Bochuan Liang, Zhengrui Li, Min Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1182277/full |
Similar Items
-
The Implication of Gastric Microbiome in the Treatment of Gastric Cancer
by: George Pappas-Gogos, et al.
Published: (2022-04-01) -
Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response
by: Hairong Su, et al.
Published: (2023-12-01) -
Machine learning approach combined with causal relationship inferring unlocks the shared pathomechanism between COVID-19 and acute myocardial infarction
by: Ying Liu, et al.
Published: (2023-03-01) -
The significance of targeting lysosomes in cancer immunotherapy
by: Yanxin Xu, et al.
Published: (2024-02-01) -
Lactate in the tumor microenvironment: A rising star for targeted tumor therapy
by: Zhangzuo Li, et al.
Published: (2023-02-01)